Article

YTHDF2 upregulation and relocation dictate CD8 T cell polyfunctionality in tumor immunity

medRxiv · 2024 · Zhang, H.; Luo, X.; Yang, W.; Wu, Z.; Zhao, Z.; Pei, X.; Zhang, X.; Chen, C.; Lei, J. H.; Shi, Q.; Zhao, Q.; Chen, Y.; Wu, W.; Zeng, Z.; Ju, H.-Q.; Qiu, M.; Liu, J.; Shen, B.; Chen, M.; Chen, J.; Deng, C.-X.; Xu, R.-H.; Hou, J.

Key facts

Title YTHDF2 upregulation and relocation dictate CD8 T cell polyfunctionality in tumor immunity
First author Zhang, H.; Luo, X.; Yang, W.; Wu, Z.; Zhao, Z.; Pei, X.; Zhang, X.; Chen, C.; Lei, J. H.; Shi, Q.; Zhao, Q.; Chen, Y.; Wu, W.; Zeng, Z.; Ju, H.-Q.; Qiu, M.; Liu, J.; Shen, B.; Chen, M.; Chen, J.; Deng, C.-X.; Xu, R.-H.; Hou, J.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.07.11.603088
Devices mentioned BK110039, DEN000008, K022086, K103302, K800781
Product codes mentioned JCI, JCJ, KIP, KIT, NDS, NJT, OOI, PFF, PFT, KIS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature